Abstract

Introduction: Major obstetric haemorrhage (MOH) is a leading cause maternal morbidity/mortality. [1] Knight M, Bunch K, Tuffnell D et al. (Eds.) on behalf of MBRRACE-UK. Saving Lives, Improving Mothers’ Care- Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2015 –17. Oxford: National Perinatal Epidemiology Unit, University of Oxford 2019. Google Scholar Optimal blood and blood product transfusion is pivotal to preventing coagulopathy, and complements pharmacological/surgical treatments. We reviewed management of MOH in our unit.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.